Medicine Overview of Osicent 80mg Tablet
Osimertinib is a kinase inhibitor indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test.
Diarrhea, rash, dry skin, and nail toxicitys
80 mg orally once daily, with or without food..
Osimertinib is kinase inhibitor of the epidermal growth factor receptor (EGFR), which binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion) at approximately 9-fold lower concentrations than wild-type.
Interaction with alcohol is unknown. Please consult your doctor.
There are no available data on Osimertinib use in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Please consult your doctor.
Lactating woman should be advised not to breastfeed during treatment
Osimertinib may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Osimertinib should be used with caution in patients with kidney disease.Please consult your doctor.
Please consult your doctor.